Wesana Health Holdings Inc.
WSNAF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $33 | $157 | $100 | $162 |
| SG&A Expenses | $33 | $157 | $104 | $166 |
| Sales & Mktg Exp. | $0 | $0 | $5 | $4 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $33 | $157 | $104 | $166 |
| Operating Income | -$33 | -$157 | -$104 | -$166 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$4 | -$39 | -$151 | $32 |
| Pre-Tax Income | -$37 | -$196 | -$255 | -$134 |
| Tax Expense | $0 | -$0 | -$43 | $0 |
| Net Income | -$37 | -$196 | -$211 | -$740 |
| % Margin | – | – | – | – |
| EPS | -0.001 | -0.006 | -0.006 | -0.035 |
| % Growth | 82.1% | 8.2% | 82.8% | – |
| EPS Diluted | -0.001 | -0.006 | -0.006 | -0.035 |
| Weighted Avg Shares Out | 35,039 | 35,039 | 35,039 | 20,920 |
| Weighted Avg Shares Out Dil | 35,039 | 35,039 | 35,039 | 20,920 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | -$63 |
| Interest Expense | $4 | $1 | $1 | $6 |
| Depreciation & Amortization | $0 | -$38 | $0 | $0 |
| EBITDA | -$33 | -$195 | -$211 | -$128 |
| % Margin | – | – | – | – |